BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37956384)

  • 1. HBeAg testing is better than quantitative HBsAg assay as an alternative to HBV DNA assay among HBV-infected pregnant women.
    Nguyen MN; Nguyen TTH; Pham TDH; Khuu VN; Hoang QC; Nguyen VT; Tran NH
    J Infect Dev Ctries; 2023 Oct; 17(10):1489-1492. PubMed ID: 37956384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 3. A cautionary note to hepatitis B e antigen (HBeAg)-negative test results in pregnant women in an area prevalent of HBeAg-negative chronic hepatitis B.
    Chalid MT; Turyadi ; Ie SI; Sjahril R; Wahyuni R; Nasrum Massi M; Muljono DH
    J Med Virol; 2023 Jan; 95(1):e28125. PubMed ID: 36064856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk.
    Samadi Kochaksaraei G; Congly SE; Matwiy T; Castillo E; Martin SR; Charlton CL; Coffin CS
    Liver Int; 2016 Nov; 36(11):1604-1610. PubMed ID: 27059287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis.
    Boucheron P; Lu Y; Yoshida K; Zhao T; Funk AL; Lunel-Fabiani F; Guingané A; Tuaillon E; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):85-96. PubMed ID: 32805201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
    Eke AC; Eleje GU; Eke UA; Xia Y; Liu J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008545. PubMed ID: 28188612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study.
    Ségéral O; N'Diaye DS; Prak S; Nouhin J; Chhun S; Khamduang W; Chim K; Roque-Afonso AM; Piola P; Borand L; Ngo-Giang-Huong N; Rouet F;
    J Clin Virol; 2018 Dec; 109():29-34. PubMed ID: 30388664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B.
    Wang R; Zhu X; Zhang X; Liu H; Ji YL; Chen YH
    World J Gastroenterol; 2023 May; 29(19):3003-3012. PubMed ID: 37274802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B e Antigen (HBeAg) Rapid Test and Alanine Aminotransferase Level-Based Algorithm to Identify Pregnant Women at Risk of HBV Mother-to-Child Transmission: The ANRS 12345 TA PROHM Study.
    Segeral O; Dim B; Durier C; Prak S; Chhim K; Vong C; Pech S; Tiv S; Nem B; Hout K; Nouhin J; Chhun S; Borand L
    Clin Infect Dis; 2020 Dec; 71(10):e587-e593. PubMed ID: 32188982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria.
    Ndububa D; Kuti O; Awowole I; Adekanle O; Ijarotimi O; Makinde O; Adeyemi A; Anyabolu C; Ijadunola M
    BMJ Open; 2022 Nov; 12(11):e063482. PubMed ID: 36351715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate.
    Chang HL; Wen WH; Lee CN; Chiu YE; Liu CJ; Chang MH; Lin LH; Chen HL
    J Viral Hepat; 2022 Feb; 29(2):107-114. PubMed ID: 34724288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HBV-DNA and HBeAg as antiviral therapeutic indicators among HBV-infected pregnant women: a systematic review and meta-analysis.
    Liu X; Chen C; Jiang D; Cui D; Yan D; Zhou Y; Ding C; Lan L; Huang C; Zhang X; Li L; Zhu C; Yang S
    Ann Palliat Med; 2021 Sep; 10(9):9362-9371. PubMed ID: 34379980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China.
    Chen T; Wang J; Qiu H; Yu Q; Yan T; Qi C; Cao F; Tian Z; Guo D; Yao N; Yang Y; He Y; Zhao Y; Liu J
    Medicine (Baltimore); 2018 Jul; 97(27):e11406. PubMed ID: 29979437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HBsAg levels in guiding hepatitis B virus prophylaxis in pregnancy: Insights from a multi-ethnic cohort.
    Mak LY; Koffas A; Dolman GE; Saleh H; Kemos P; Riddell A; Gill U; Kennedy PTF
    J Viral Hepat; 2024 Jan; 31(1):3-11. PubMed ID: 37881873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
    Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
    Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North America.
    Samadi Kochaksaraei G; Castillo E; Sadler MD; Seow CH; Barkema HW; Martin SR; Israelson H; Pinto J; Williams S; Aspinall AI; Stinton LM; Borman MA; Burak KW; Swain MG; Congly SE; Lee SS; Shaheen AA; Coffin CS
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1707-1716. PubMed ID: 33111382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.